Tagworks Pharmaceuticals
PrivateLast Round
Series A
Jun 22, 2023
Total Funding Raised
$74M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tagworks Pharmaceuticals operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a Series A round in June 2023.
Tagworks Pharmaceuticals is a biotechnology company that develops precision oncology treatments using its proprietary Click-to-Release technology to enable controlled drug release in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tagworks Pharmaceuticals Comparables
Compare Tagworks Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shasqi | 86% | |
| Seekyo | 83% | |
| Adcendo | 79% |
For institutional investors. Book with your work email.
Tagworks Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 22, 2023 | ||||
| Seed | Nov 27, 2021 | ||||
| Grant | Dec 18, 2015 |
For institutional investors. Book with your work email.
Tagworks Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIF Partners | Seed, Series A |
| New Enterprise Associates | Series A |
| Lightstone Ventures | Series A |
| Ysios Capital | Series A |
| Gilde Healthcare | Series A |
| European Union's Horizon 2020 | Grant |
| Meneldor | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 161% MoM.
- Nov 7, 2025
Presenting at PEGS Summit Europe in Lisbon.
For institutional investors. Book with your work email.
Tagworks Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tagworks Pharmaceuticals's valuation, stock price, and market status.
Is Tagworks Pharmaceuticals a public or private company?
Tagworks Pharmaceuticals is a private company.
What is the current stock price of Tagworks Pharmaceuticals?
Tagworks Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Tagworks Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tagworks Pharmaceuticals worth (valuation)?
Valuation information for Tagworks Pharmaceuticals is not publicly available.
Can I buy Tagworks Pharmaceuticals stock?
Tagworks Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tagworks Pharmaceuticals's last funding round?
Tagworks Pharmaceuticals's most recent funding round was Series A on June 22, 2023.
Who are the main investors in Tagworks Pharmaceuticals?
Key investors in Tagworks Pharmaceuticals include Ysios Capital, Gilde Healthcare, Meneldor, Oost NL, East Netherlands Development Agency (Oost NL).
Will Tagworks Pharmaceuticals IPO soon?
No public IPO plans have been announced for Tagworks Pharmaceuticals.
How can I track Tagworks Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Tagworks Pharmaceuticals's shares on secondary markets.